<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03245957</url>
  </required_header>
  <id_info>
    <org_study_id>2016/CHU/06</org_study_id>
    <nct_id>NCT03245957</nct_id>
  </id_info>
  <brief_title>HDL Dysfunction During the Acute Stage of Stroke</brief_title>
  <acronym>RUSH</acronym>
  <official_title>HDL Dysfunction During the Acute Stage of Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de la Réunion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de la Réunion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigates the effect of plasma myeloperoxidase (MPO) concentrations on HDL
      dysfunction during the acute stage of ischemic and haemorrhagic strokes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MRI or CT scan are used to confirm the diagnosis of haemorrhagic, ischemic and mimick stroke.

      Plasma anf HDL-MPO concentrations, as well as potent HDL dysfunction, are compared in the 3
      cases.

      The investigators hypothesis is that MPO concentrations and subsequent HDL dysfunction could
      be higher in ischemic strokes than in haemorrhagic ones. MPO could be a examined as a potent
      marker of early stage of ischemic stroke.

      Plasma MPO levels could also be discriminant regarding the mimick strokes in patient
      exhibiting stroke clinical picture.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2017</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma MPO concentrations</measure>
    <time_frame>Through study completion, an average of 6 hours</time_frame>
    <description>Assessment of plasma MPO concentrations during acute stage of stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HDL-MPO concentrations</measure>
    <time_frame>Through study completion, an average of 6 hours</time_frame>
    <description>Assessment of HDL-MPO concentrations during acute stage of stroke</description>
  </secondary_outcome>
  <other_outcome>
    <measure>HDL dysfunction</measure>
    <time_frame>Through study completion, an average of 6 hours</time_frame>
    <description>Assessment of HDL function using inhibition test on cell culture</description>
  </other_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>Ischemic stroke</arm_group_label>
    <description>Patients with ischemic stroke diagnosed by MRI or CT scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Haemorrhagic stroke</arm_group_label>
    <description>Patients without haemorrhagic stroke diagnosed by MRI or CT scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mimick stroke</arm_group_label>
    <description>Patients without haemorrhagic or ischemic stroke diagnosed by MRI or CT scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ischemic stroke</intervention_name>
    <description>Patients with acute stage of stroke clinical picture, with ischemic, haemorrhagic or mimick stroke diagnosed using MRI or CT scan</description>
    <arm_group_label>Ischemic stroke</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Haemorrhagic stroke</intervention_name>
    <description>Patients with acute stage of stroke clinical picture, with ischemic, haemorrhagic or mimick stroke diagnosed using MRI or CT scan</description>
    <arm_group_label>Haemorrhagic stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with clinical picture of early stage of stroke with the first signed lasting
        for less than 12 hours
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with less than 12 hours stroke clinical signs:

          -  hemiparesis or hemiplegia

          -  unilateral sensitivity disorder

          -  language impairment

          -  balance disorder

          -  dizziness, bilateral or monocular vision totally or partially lost

        Exclusion Criteria:

          -  Pregnancy

          -  head trauma since the last 3 months

          -  stroke since the last 3 months

          -  myocardial infarction since the last 3 months

          -  patient disagrees to be enrolled in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David COURET, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hpospitalier Universitaire de La REUNION</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine JUHEL, PHD</last_name>
    <phone>+262262359949</phone>
    <email>christine.juhel@chu-reunion.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David COURET, MD</last_name>
    <phone>+262262359000</phone>
    <email>david.couret@chu-reunion.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chu Reunion Island</name>
      <address>
        <city>Saint-Pierre</city>
        <state>Reunion Island</state>
        <zip>97410</zip>
        <country>Réunion</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>COURET DAVID, MD</last_name>
      <phone>+262262359000</phone>
      <email>david.couret@chu-reunion.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>Réunion</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2017</study_first_submitted>
  <study_first_submitted_qc>August 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2017</study_first_posted>
  <last_update_submitted>December 18, 2017</last_update_submitted>
  <last_update_submitted_qc>December 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

